Purpose

This study aims to look at the effectiveness of using repetitive transcranial magnetic stimulation (rTMS) in relieving pain and other co-morbid symptoms of Gulf War Illness.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 65 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male or female under 65 years of age who served in the military for at least 30 consecutive days between August 1, 1990, and July 31, 1991 in the Persian Gulf War region - CDC Criteria for GWVI (GWI) - Kansas Criteria for GWVI (GWI) - International Headache Society Criteria for Migraine Headache without aura - Average Overall Daily Muscle Pain Intensity >3 on 0-10 a NPS - Average Overall Daily Extremities Joint Pain Intensity >3 on 0-10 a NPS - Headache Exacerbation/attack once a week with the average intensity >3 on a 0-10 NPS, lasting > 1 hour in the past three months - Hamilton Rating Scale of Depression (HRSD) greater than or equal to 14 based on the sum of scores for the first 17 items

Exclusion Criteria

  • Pregnancy - History of pacemaker implant - Any ferromagnetic (e.g. bullet fragment, shrapnel, device implant) in the brain or body that will prohibit the patients from having a brain MRI - History of dementia, major psychiatric diseases, or life-threatening diseases - Presence of any other chronic neuropathic pain states such as Complex Regional Pain Syndrome or Painful Peripheral Neuropathy - History of seizure - Pending litigation - Low back pain with mechanical origins such as lumbar radiculopathy or radiculitis or lumbar facet arthropathy - Lack of ability to understand the experimental protocol and to adequately communicate in English - History of Traumatic Brain injury - Chronic Tension or Cluster Headache - Ongoing Cognitive Rehabilitation or Treatment of PTSD

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
There will be two groups: one will receive active rTMS and the other group will receive sham rTMS.
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)
Masking Description
This is a double-blinded study where only the statistician is aware of the randomization

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Active rTMS at the LDLPFC
Subjects will receive the repetitive Transcranial Magnetic Stimulation (rTMS) study procedure at the left dorsolateral prefrontal cortex (LDLPFC).
  • Device: Transcranial Magnetic Stimulation
    A non-invasive treatment that emits magnetic pulses to stimulate the brain.
Sham Comparator
Sham rTMS at the LDLPFC
Sham rTMS will appear the same as the active, with the same parameters, but will not receive the actual magnetic stimulation to the LDLPFC.
  • Device: Sham Transcranial Magnetic Stimulation
    Sham rTMS will consist of the same parameters as active, however, the subject will not receive the actual magnetic stimulation due to the use of a double sided Active/Sham coil used specifically for research studies.
Active Comparator
Active rTMS at the LMC
Subjects will receive the repetitive Transcranial Magnetic Stimulation (rTMS) study procedure at the left motor cortex (LMC)
  • Device: Transcranial Magnetic Stimulation
    A non-invasive treatment that emits magnetic pulses to stimulate the brain.
Sham Comparator
Sham rTMS at the LMC
Sham rTMS will appear the same as the active, with the same parameters, but will not receive the actual magnetic stimulation to the LMC.
  • Device: Sham Transcranial Magnetic Stimulation
    Sham rTMS will consist of the same parameters as active, however, the subject will not receive the actual magnetic stimulation due to the use of a double sided Active/Sham coil used specifically for research studies.

Recruiting Locations

More Details

Status
Recruiting
Sponsor
VA Office of Research and Development

Study Contact

Caleb T Lopez, BS
(858) 552-8585
caleb.lopez@va.gov

Detailed Description

Headaches (HA), muscle and joint pain, are some of the most common debilitating symptoms in military personnel served in the 1990-1991 Persian Gulf War (GW1). Migraine like HA and diffuse body pain were detected in 64% of Gulf War Veteran (GWV) diagnosed with Gulf War Illness (GWI). Likewise, depression carries a very high co-morbid rate (50%) in patients with chronic pain, and in GWV with GWI related chronic HA and body muscle and joint pain conditions (GWI-HAP). Unfortunately, conventional pharmacological treatments for GWI-related pain has not been shown to be effective and drugs such as narcotics contain many long term untoward psychosomatic and abusive side effects. This study is assessing the effectiveness of repetitive transcranial magnetic stimulation (rTMS), non-invasive treatment option, in alleviating pain and other co-morbid symptoms of GWI.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.